Trial Profile
A Randomized, Double-blind, Single Center, Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Seborrheic Dermatitis of the Face
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2017
Price :
$35
*
At a glance
- Drugs Asivatrep (Primary)
- Indications Seborrhoeic dermatitis
- Focus Therapeutic Use
- Sponsors AmorePacific
- 10 Jan 2017 New trial record